The chief operating officer of drug developer
has stepped down from his post, the company announced Monday.
Alfred Rudolph, who joined the company in 1997, left last Friday. Friedhelm Blobel, the company's president and CEO, will take on the COO duties.
Shares of SciClone lost 2.1% to $2.74.